Delta G Ventures to Accelerate Medical Device Readiness
PALM BEACH GARDENS, FL / CRWEPRESSRELEASE / October 14, 2015 – Delta G Ventures, LLC, a life sciences accelerator services consulting firm, opened its offices this week to prepare both early stage and established medical device companies for enhanced commercial readiness through effective strategy development, opinion leader establishment, legal and regulatory requirements, among other services. With clients signed in Florida, California, and New Jersey underway, Delta G Ventures (DGV) will work with medical and dental companies with emerging technologies throughout the world.
At the helm of Delta G Ventures, are three seasoned medical device executives, Glenn L. Criser, J.D., Lars A. Janson, M.B.A., and Edward G. Sabin, C.P.A, with 75 years of combined experience in the orthopedic, dental and cardiovascular industries. Together they developed the proprietary Growth Engine Framework™ model designed to address specific company needs and provide the right tools to achieve financial goals.
“The life sciences industry is complex and evolving. Emerging and established companies must navigate new technology growth through creative strategic planning and comprehensive cross-functional teamwork,” said managing director, Lars A. Janson.
Within the life sciences industry, the medical device sector has been strong globally, with $37 billion in revenue in 2013 and projected five year growth rate of 7% by 2019 to $52.9 billion, according to the Deloitte 2015 Life Sciences Outlook. In Florida, the life sciences industry employs 80,000 within 5,500 establishments and research organizations. (Source: Battelle/BIO State Bioscience Jobs, Investments and Innovation 2014)
"If growing early stage companies is hard work, then accelerating early stage life sciences companies is a juggernaut." says Timothy J. Cartwright, Chairman of the Tamiami Angel Fund. "The complexity of the sector when multiplied by the normal challenge of a startup creates this juggernaut. In my experience, it can be solved, but only with a special blend of business acumen, a curated network of scientists and KOLs, regulatory guidance, strategic partnerships, and entrepreneurial passion. The managing directors at Delta G Ventures bring together that special blend."
Mr. Criser, a corporate attorney, was a partner in the Steel Hector & Davis law firm, and has held numerous global leadership roles within Biomet 3i, Inc. and Biomet, Inc. in the legal, quality, regulatory and clinical groups. Mr. Janson, a medical device careerist for the past 25 years, worked for multiple business units within Johnson & Johnson and Biomet 3i, Inc. Mr. Janson excelled in all aspects of global Commercial Operations Management. As a global financial executive and administration subject matter expert, Mr. Sabin as a Vice President for Biomet, Inc. and CFO for Biomet 3i, Inc. was responsible for Global Finance and Accounting, Human Resources, IT Oversight, Quality Assurance and Control, and Regulatory Affairs.
Source: Delta G Ventures